Recent Advances in Nanotherapeutics for Neurological Disorders.

ABSTRACT: Neurological disorders remain a significant health and economic burden worldwide. Addressing the challenges imposed by existing drugs, associated side- effects, and immune responses in neurodegenerative diseases is essential for developing better therapies. The immune activation in a diseased state has complex treatment protocols and results in hurdles for clinical translation. There is an immense need for the development of multifunctional nanotherapeutics with various properties to address the different limitations and immune interactions exhibited by the existing therapeutics. Nanotechnology has proven its potential to improve therapeutic delivery and enhance efficacy. Promising advancements have been made in developing nanotherapies that can be combined with CRISPR/Cas9 or siRNA for a

SUBMITTER: Vashist A 

PROVIDER: S-EPMC10354745 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature